Kenya is ranked seventh as one of the nations significantly impacted by reductions in U.S. foreign assistance, highlighting the nation’s significant reliance on funding from donors, particularly within the realm of health care services.
The nation has received approximately $1.7 billion (
Sh
220.15 billion)
in aid
In the past three years, a significant portion from the United States has been allocated to health services.
This is according to official data from the US Agency for International Development (
Usaid
)
website
For the years 2023, 2024, and the accessible data from 2025.
The distribution pattern of aid in Kenya shows
A significant portion of the funds is allocated to HIV/AIDS programs; economic growth initiatives; farming activities; various healthcare projects; supplying clean water and improving sanitation; providing emergency aid; covering operational costs; offering programmatic support; safeguarding the environment generally; as well as promoting democracy, human rights, and good governance, in that order.
The examination utilized funding data supplied by
Usaid
to analy
s
It allocates international assistance from 2023 to 2025 and identifies the areas needing the highest expenditure by 2025.
“The final ranking is determined by the overall quantity of assistance received by the nation during this period,” stated Slot.day, who examined the information, with validation provided by
The Star
.
The
Usaid
The data indicate that the U.S. has kept up significant financial support for HIV.
Aids
program
me
As seen in Kenya, where the sector received $66 million (
Sh
(€8.54 billion) for 2025 allocations.
Nevertheless, Kenya’s financial assistance from the U.S. has been declining, with funds dropping from $846 million (
Sh
109.53 billion) in 2023 down to $128 million (
Sh
16.57 billion) in 2025.
Although the entire assistance package amounts to $1.7 billion (
Sh
The $220.15 billion committed over three years shows significant support from the U.S., but the decreasing pattern in yearly funding might jeopardize years of advancements in public health programs, according to the analysis.
The previous week, the World Health Organization highlighted that Kenya was one of eight nations—six from Africa—that might face shortages of HIV medications due to the U.S. government’s choice to halt international financial assistance.
Nevertheless, Kenya’s Ministry of Health attempted to alleviate concerns by stating that the nation currently possesses sufficient antiretroviral drugs (ARVs) to cover a period of four months. They also mentioned that additional supplies are en route, which will elevate Kenya’s ARV inventory to a level adequate for maintaining supply until June 2025.
On his inaugural day in January, US President Donald Trump declared a freeze on federal expenditures as part of an assessment into governmental budgeting.
“Interruptions to HIV programs might reverse two decades of advancements,” cautioned WHO Director-General Tedros Adhanom Ghebreyesus last Monday.
He further mentioned that it could result in over 10 million extra HIV cases along with an additional three million HIV-related fatalities. This figure, he noted, is “more than triple the mortality rate from last year.”
According to Dr. Tedros during a recent press briefing, Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso, and Mali – along with Haiti and Ukraine – face the risk of exhausting life-sustaining antiretroviral (ARV) medications within the next few months.
Trump’s executive order paused foreign aid support for an initial duration of 90 days in line with his “America First” foreign policy.
This issue has impacted global health programs, significantly impeding the delivery of essential medical supplies such as HIV medications worldwide.
Most of the programs run by the United States Agency for International Development (USAID) have now been discontinued.
Even with a waiver granted in February for the U.S.’s pioneering HIV program, its operations have been significantly affected.
Referred to as the President’s Emergency Plan for AIDS Relief (PEPFAR), this initiative depends on logistic assistance provided by USAID and various organizations affected by the unrest.
Dr. Tedros stated that this situation has resulted in the “sudden halt of HIV treatment, testing, and prevention services across more than 50 nations”.
Introduced in 2003, Pepfar has provided millions of impoverished individuals around the globe with life-saving medications and is estimated to have saved over 26 million lives across the planet.
Last week, Kenya’s Ministry of Health announced that the nation possesses almost five months’ worth of inventory for the frequently utilized ARVs referred to as TLD, which stands for a regimen combining Tenofovir, Lamivudine, and Dolutegravir.
This is the primary ART regimen utilized by over 92 percent of all Kenyan individuals living with HIV.
The Health Cabinet Secretary, Dr. Deborah Barasa, stated that as of now, there are 2,026,555 packs of TLD available with both the Kenya Medical Supplies Authority (KEMSA) and their subcontractor, Mission for Essential Drugs and Supplies (MEDS). This supply amounts to approximately 4.7 months’ worth of stock.
She mentioned that an additional 4.8 million packages will be delivered to Kenya by June of this year. “By the end of June 2025, this will boost the national-level inventory to more than 11 months’ worth of supplies,” Dr. Deborah stated.
Approximately 1.4 million individuals in Kenya are affected by HIV, and over 95 percent of these people are receiving treatment.
